Synthomer PLC

The company's capital structure shows a debt-to-equity ratio of 0.91, indicating moderate leverage. With GBP 189.9 million in cash and equivalents but GBP 818.5 million in long-term debt, the net cash position is negative by GBP 628.6 million. Free cash flow is negative at GBP -107.4 million, driven by GBP -87.7 million in capital expenditures. The current ratio of 1.57 suggests acceptable short-term liquidity.

Profitability metrics show significant underperformance: return on equity of -17.43% and return on assets of -6.88%. These results fall well below the industry's median performance for specialty chemicals, where positive returns are typically expected. Operating income of GBP -50.2 million and net income of GBP -157 million highlight operational challenges.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of segmentation data limits visibility into regional exposure and risk distribution.

Revenue growth appears to be negative, with GBP 1.74 billion in revenue for the latest period. No forward-looking guidance is provided in the input data, but the negative operating and net income suggest a challenging growth trajectory. Analysts have issued a mixed outlook, with a mean price target of GBP 127.25 and a median of GBP 83.50.

Risk factors include liquidity concerns due to negative net cash and the potential for operational underperformance to persist. Dilution risk is assessed as low, with no recent share issuance activity and basic and diluted shares outstanding remaining equal at 163.57 million. No adjustments were applied to valuation metrics in the custom valuations.

Recent filings show a continuation of operating losses and capital expenditures outpacing operating cash flow. No material events were disclosed in the latest transcripts or filings beyond the standard financial reporting.